Skip to content

    Sagility India

    SAGILITY
    Information Technology·25 Mar 2026
    Management Summary

    Sagility India's Q4 FY26 Investor & Analyst Day highlighted the company's strategic pivot towards AI-led transformation in the US healthcare sector, positioning AI as a force multiplier. The company reported strong growth across its client base, with top clients growing 9.9% and others 28% in the last 12 months, driven by outcome-based managed services and Synchrony solutions. Sagility demonstrated significant client value creation, such as converting a $6 million opportunity into a $20 million deal and reducing $15 million in late claim interest. While acknowledging industry challenges like regulatory complexity and fragmented data, Sagility remains confident in its domain expertise and proprietary technology to drive future growth and maintain strong EBITDA margins of 24-25%.

    Highlights

    5
    • Top five clients demonstrated robust growth of 9.9% in the last 12 months (Dec 2025 over 2024), indicating strong client relationships.

    • Growth from other clients was even healthier at 28% over the same period, showcasing broader market penetration.

    • A managed services deal exemplified Sagility's value proposition, transforming a $6 million revenue into a $20 million deal, with a potential to grow to $100 million, representing a 3.5x revenue increase.

    • Sagility's AI-led Nurse Assist solution received the Augmented Intelligence Award, validating its technological innovation.

    • Successfully delivered significant cost avoidance for clients, including a $15 million reduction in late claim payment interest for one client through an AI-led command center.

    Concerns

    3
    • The US healthcare industry faces significant membership volatility and margin compression, with payers spending over 90% of premiums on claims.

    • Regulatory complexity, fragmented data, and legacy systems in US healthcare pose inherent constraints and challenges for widespread AI implementation.

    • AI implementation can be costly, especially with large language models, requiring careful selection of models to balance cost, accuracy, and latency, and models can hallucinate or drift.

    Key financials

    Metrics

    3

    Periods

    2

    Headline

    1
    • EBITDA Margin Range
      24-25 %

    LTM

    2
    • Top 5 Clients Revenue Growth
      9.9%
      YoY+9.9%
    • Other Clients Revenue Growth
      28%
      YoY+28.0%

    Segment breakdown

    Payers
    87.5% Revenue Share
    Providers
    12.5% Revenue Share
    List

    Order Book

    high confidence

    Total Value

    USD 20 million

    as of 2026-03-31

    quantified

    Execution

    over five year or less

    Pipeline

    deal pipeline tcv

    overall enterprise pipeline of projects

    "Sagility is converting smaller opportunities into larger, outcome-based managed services deals, with a significant enterprise pipeline."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Debt

    Debt disclosed

    M&A

    BroadPath

    acquisition · integrated

    M&A

    DCI

    acquisition · integrated

    M&A

    Clinical Domain Targets

    acquisition · announced

    Guidance & targets

    3
    CategoryTargetPriority
    Revenue Growth
    Overall Revenue Growth
    low double-digits to mid-teens
    Medium
    Profitability
    EBITDA Margin
    24-25%
    High
    Revenue Productivity
    Revenue per FTE (Geo Level)
    significant movement upwards
    Medium

    Overall Revenue Growth Guidance for FY27

    next quarter (during earnings call)
    Currentlow double-digits to mid-teens (historical rates)
    TargetSpecific guidance for the next financial year

    Why it matters

    To assess if Sagility provides more precise growth guidance for FY27, confirming its confidence in AI-led expansion and market strategy.

    But specific guidances for the next financial, we will give closer to the earnings call.

    How to verify

    guidance_and_targets[category='Revenue Growth'][metric='Overall Revenue Growth']

    Risks & concerns

    4
    RiskSeverity

    Membership volatility and margin compression in US healthcare.

    Payers are spending over 90% of premiums on claims, leaving little for operations and profit, leading to margin compression and some exiting high-utilization markets. Sagility views this as a tailwind for its cost-reduction services.Management acknowledged

    high

    Regulatory complexity and constraints on AI implementation in US healthcare.

    Laws like HIPAA impose strict guardrails on data access and usage, and clinical decisions often require human involvement, limiting autonomous AI decision-making. Sagility ensures AI solutions are auditable, explainable, and compliant.Management acknowledged

    medium

    Fragmented data and legacy systems in US healthcare.

    Information across the ecosystem (membership, billing, claims) is siloed, with limited data exchange and restricted access, complicating AI integration. Sagility's domain expertise helps navigate these constraints.Management acknowledged

    medium

    AI implementation costs and potential for errors/hallucinations.

    Building AI solutions on foundational models can be costly, and AI models can hallucinate or drift, necessitating careful selection of models, robust engineering, and human oversight.Management acknowledged

    low

    Q&A highlights

    7

    “I think Roopam who comes after me is going to give you a real-life example. So I don't want to steal his thunder. But the broad response to your question is, we are looking at Al as a force multiplier. We are not looking at Al as a disruptor.”

    Addresses a core investor concern about AI's disruptive potential and how Sagility views it as an opportunity rather than a threat.

    asked by Atul Mehra

    3 min read6 chapters

    Detailed Narrative

    01

    AI as a Force Multiplier in Healthcare Operations

    Sagility positions AI and Agentic AI as a force multiplier, not a disruptor, for its business, aiming to accelerate growth. The company is embedding AI into end-to-end workflows through 'SmarTec agents' to automate complex processes and improve efficiency. This approach is expected to open up additional opportunities, especially given the cost and margin pressures faced by clients. Sagility emphasizes its 25 years of domain depth and understanding of the healthcare ecosystem as key differentiators in deploying AI effectively.

    02

    US Healthcare Market Dynamics and Sagility's Positioning

    The US healthcare system is experiencing significant changes, including membership volatility and margin compression, with payers spending over 90% of premiums on claims. Sagility sees these challenges as a tailwind, as clients increasingly seek partners to reduce operational costs and improve profitability. The company's deep domain expertise and transformation capabilities allow it to offer low-transition-cost solutions, with top five clients growing 9.9% and other clients growing 28% in the last 12 months (Dec 2025 over 2024).

    03

    Managed Services and Outcome-Based Offerings

    Sagility is shifting towards outcome-based managed services, leveraging AI to grow faster and gain market share. These deals focus on committed cost savings and speed to value, with zero upfront CapEx for clients. An example cited is a managed services deal that transformed a $6 million revenue opportunity into a $20 million deal, with a potential to reach $100 million, representing a 3.5x revenue growth. Sagility's incumbency and strong delivery track record build trust, enabling it to secure these end-to-end managed service contracts.

    04

    Mid-Market Expansion and Synchrony Solutions

    Sagility's 'Synchrony' solutions integrate technology platforms with operations to provide end-to-end services, particularly targeting the mid-market (clients with less than a million members). These solutions, like 'Medicare Synchrony,' cover entire lifecycles from enrolment to billing, offering faster value and increased stickiness for clients. The company is bullish on penetrating the mid-market, which often lacks the underlying technology and resources to implement such integrated solutions internally, seeing it as a significant growth driver.

    05

    AI-Led Clinical Transformation and MLR Reduction

    Sagility is applying AI to clinical practice to address rising medical costs and improve quality of care, focusing on MLR (Medical Loss Ratio) reduction. Solutions like 'Nurse Assist' (an award-winning generative AI tool) streamline prior authorizations and care management. By integrating AI with human expertise, Sagility aims to reduce waste, improve patient outcomes, and lower readmission rates, with programs showing 3x to 5x ROI and 5-15% impact on medical spend. An example showed a $24 million savings in UM operations and a $15 million reduction in late claim payment interest for clients.

    06

    Technology Strategy and Partner Ecosystem

    Sagility's technology strategy involves building modular 'building blocks' over 10+ years, including predictive AI models, RPA, and generative AI capabilities. The company partners with platform vendors (e.g., AWS, Azure) and system integrators to deliver end-to-end solutions, rather than building enterprise applications itself. This ecosystem approach allows for rapid assembly of solutions, ensuring deployability and maintainability while adhering to client technology guardrails and regulatory compliance (SOC2, HiTrust).

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.